Aurore Perrot

77PUBLICATIONS
200CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHaematological tumoursNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (77)

|Jul 03, 2026
Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial.

|Jul 02, 2026
Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

|Jun 15, 2026
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

|Jun 12, 2026
Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.

|Jun 08, 2026
Outpatient Rescue With Stem Cells Boost for Refractory Hematotoxicity Following anti-BCMA CAR T-Cell Therapy: A Case Report.

|Jun 03, 2026
Daratumumab in Transplant-Ineligible or -Deferred Newly Diagnosed Multiple Myeloma: Minimal Residual Disease in CEPHEUS.

Pageof 13

Frequent Collaborators

29 joint publications

Jill Corre

22 joint publications

Xavier Leleu

13 joint publications

Philippe Moreau

10 joint publications

Mohamad Mohty